UK CBD Law 2026: Complete Compliance Guide
Overview: UK CBD Regulations in 2026
UK CBD regulation has become significantly more structured since 2021, with the Food Standards Agency (FSA) playing a central role. As of 2026, the FSA recommends a 10mg acceptable daily intake (ADI) for CBD and has introduced tougher safety and labelling standards. It is important to note that the 10mg ADI is advisory guidance, not a legally enforced limit. Businesses are strongly encouraged to reformulate products in line with this recommendation, but it is not mandated.
Selling products that exceed THC limits or that are classed as controlled drugs can carry severe criminal penalties. These penalties exist under existing law (the Misuse of Drugs Act 1971) specifically for supplying products that exceed the 1mg THC-per-container limit, which classifies them as Class B controlled drugs. Penalties for the supply of Class B drugs can reach up to 14 years in prison, and this is distinct from the novel food authorisation regime.
Key Points at a Glance
- CBD Products: Must be listed on the FSA Public List under a validated novel food application and meet the exempt product criteria (no more than 1mg of controlled cannabinoids per container).
- Illegal Items: CBD flowers, buds, and unregulated products remain banned.
- Labelling: Products must include safety warnings for under-18s, pregnant women, breastfeeding women, those trying to conceive, and those on medication.
- Testing: Labs must comply with ISO/IEC 17025 standards to confirm THC levels and product safety.
- Driving & Workplace: THC exposure from certain CBD products could lead to failed drug tests or driving offences.
How UK CBD Laws Have Changed Over Time?
2018: Changes to the Misuse of Drugs Act
The first major shift came in 2018 when the government rescheduled cannabis-based medicinal products under the Misuse of Drugs Regulations 2001. These products moved from Schedule 1 to Schedule 2, allowing specialist doctors to prescribe cannabis-derived medicines without needing a Home Office licence.
While pure CBD isolate itself is not a controlled substance, the extraction process often results in trace amounts of THC. To qualify as an exempt product, the entire container must not exceed 1mg of controlled cannabinoids. Products are also required to undergo testing in accredited laboratories meeting ISO/IEC 17025 standards.
2021: Introduction of Novel Foods Regulation
In 2021, the FSA introduced stricter rules for CBD products sold as food or supplements. From 31 March 2021, all new CBD products required full authorisation from the FSA. Existing products could remain on the market temporarily, provided businesses submitted a novel food application by the deadline. Products without valid applications were required to be removed from sale immediately.
October 2023: FSA Lowers the Recommended Daily CBD Intake
In October 2023, not 2026, the FSA reduced its recommended acceptable daily intake (ADI) for CBD from 70mg/day to 10mg/day for healthy adults weighing 70kg. This change was based on new evidence indicating that long-term daily use above this level could contribute to adverse effects on the liver and thyroid. This ADI is an advisory recommendation and is not legally mandated.
2026: Latest FSA Updates
The regulatory framework was updated further in 2026 in two key ways:
- Switching Applications Policy (February 2026): The FSA introduced a policy allowing businesses to transfer products between novel food applications if their original submissions were stalled or withdrawn, provided the product specifications align with the receiving application.
- THC Safe Upper Limit: The FSA confirmed a THC safe upper daily limit of 0.07mg (70 micrograms) per day for healthy adults.
- Labelling Updates: New guidance requires warnings that products are unsuitable for those under 18, pregnant or breastfeeding women, those trying to conceive, and individuals on medication or who are immunosuppressed.
- Authorisation Timeline: The FSA is on track to make formal recommendations for CBD authorisations to ministers in Autumn 2026.
In January 2026, the FSA demonstrated its tougher stance by rejecting application RP194 from Dragonfly Biosciences Limited. Despite proposing a CBD isolate for food supplements at 70mg/day, the application was denied due to insufficient data and a lack of administrative provenance. In contrast, in April 2025, The London Company Ltd received a positive safety assessment (RP340) for its CBD isolate (≥98% purity), deemed safe for food supplements at 10mg/day.
Main Laws That Control CBD in the UK
The Misuse of Drugs Act 1971 (MDA)
The MDA categorises cannabis and its controlled cannabinoids, including THC, THC-V, and Cannabinol, as Class B controlled substances. Pure CBD, when isolated, is not classified as a controlled substance under the MDA. However, CBD extraction often leaves trace amounts of controlled cannabinoids, meaning many products could technically fall under its scope.
To legally sell CBD without a Home Office licence, products must meet the Exempt Product Definition (EPD) under Regulation 2 of the Misuse of Drugs Regulations 2001:
- The product must not be designed for the administration of controlled substances.
- The controlled substance cannot be recovered using readily applicable methods.
- No single container can contain more than 1mg of any controlled cannabinoid.
Raw CBD flowers and leaves remain illegal under UK law regardless of THC content, as they fall under the classification of Class B controlled drugs.
Novel Foods Regulation
Since January 2019, CBD has been classified as a novel food in the UK, requiring pre-market authorisation from the FSA before it can be legally sold in Great Britain. Products available before 13 February 2020 and with applications submitted by 31 March 2021 can remain on the market while awaiting approval, provided they appear on the FSA's Public List.
New CBD products introduced after 13 February 2020 cannot be sold unless they receive full authorisation; a validated application alone does not suffice. The FSA recommends a provisional ADI of 10mg of CBD per day for a healthy adult weighing 70kg. Manufacturers are advised to adjust formulations so servings do not exceed this guideline. This is advisory guidance, not a mandated legal requirement.
Authorisation is tied to both the ingredient and the production method. If a manufacturer changes their extraction process, existing authorisation may no longer apply.
THC Limits and Testing Requirements
Two key THC limits are in place:
-
Industrial hemp cultivation: Only permitted under a Home Office licence; the THC content of the hemp plant must not exceed 0.2%.
- Consumer products: The total amount of controlled cannabinoids in a finished product must not exceed 1mg per container. For example, a 30ml bottle of CBD oil must contain less than 1mg of all controlled cannabinoids combined.
The FSA has also confirmed a safe upper daily limit for Delta-9 THC of 70 micrograms (0.07mg) for healthy adults. Testing must be conducted by laboratories accredited to ISO/IEC 17025 standards, such as UKAS-approved facilities. Consumers and retailers are encouraged to request a Certificate of Analysis (CoA) to verify compliance.
|
How to Buy CBD Legally in the UK?
If you want to buy CBD products legally in the UK, do follow these checklists:
- Check the FSA Public List: Look for products listed as 'Validated' or 'Awaiting Evidence'. These are legally allowed to remain on the market while undergoing safety assessments. Avoid anything marked 'Removed'.
- Request a Certificate of Analysis (CoA): This lab report must come from an ISO/IEC 17025 accredited laboratory, confirming no more than 1mg of controlled cannabinoids per container.
- Review the Label: Proper labelling should include safety warnings for under-18s, pregnant or breastfeeding women, those trying to conceive, and anyone on medication.
- Consider the Daily CBD Limit: The FSA recommends a maximum daily dose of 10mg of CBD for healthy adults. This is advisory guidance, suggesting that higher doses may not align with FSA safety guidelines, though exceeding 10mg is not itself illegal for consumers.
Red Flags to Watch Out For
- CBD Flowers, Buds, or Tops: These remain illegal in the UK. Possession can lead to criminal prosecution under the Misuse of Drugs Act 1971.
- Medicinal Claims: Products claiming to cure, treat, prevent, or heal conditions must be licensed as medicines by the MHRA. Without this, such claims are unlawful.
- Missing Documentation: Absence of lab reports, FSA registration, or mandatory safety warnings is a clear sign of non-compliance.
How Originals CBD Meets Legal Standards?
Originals CBD takes compliance seriously, using third-party ISO/IEC 17025 accredited labs to test all products. These tests confirm that each container adheres to the 1mg THC limit required by UK law. Products are formulated in line with FSA guidance, including the recommended 10mg/day ADI, and come with Certificates of Analysis for full transparency.
In addition to rigorous testing, Originals CBD sources products from sustainable farms and provides clear labelling with all mandatory safety warnings for vulnerable groups. All products are listed in connection with valid FSA novel food applications.
Legal Requirements for Selling CBD in the UK
CBD extracts and isolates are classified as novel foods in the UK and require pre-market authorisation from the FSA. The application process involves submitting a detailed dossier covering administrative details, technical data, and safety evidence specific to the ingredient and production method. The dossier undergoes validation, risk assessment, public consultation, and final review.
Authorisation applies only to the specific product and production method. The FSA is on track to make formal recommendations for CBD authorisations to ministers in Autumn 2026. Until then, products with validated applications on the FSA Public List may remain on sale.
1. Labelling and Marketing Rules
Labels must clearly state the CBD content per serving, the total number of servings, and include all mandatory safety warnings. These warnings must specify that the product is unsuitable for individuals under 18, pregnant or breastfeeding women, those trying to conceive, and anyone taking medication or who is immunosuppressed.
As per the FDA, the maximum acceptable daily intake (ADI) of CBD for an adult is 10mg per day. If you consume a CBD product that has an individual serving of 10mg/day, only one product type per day should be consumed to ensure the ADI is not exceeded.
Businesses must not make medicinal claims (such as that a product can 'cure', 'restore', 'prevent', or 'heal') unless it is licensed as a medicine by the MHRA. No health claims for CBD are currently authorised in the UK. Marketers must also avoid implying that FSA Public List status equates to FSA 'approval' or 'authorisation'.
2. Licensing for Controlled Cannabinoids
Pure CBD isolate is not a controlled substance, but many CBD products contain trace amounts of controlled cannabinoids such as THC, THC-V, and CBN. If a product does not meet the Exempt Product Definition outlined above, it is classified as a Class B controlled drug, making it illegal to possess, supply, produce, or import without a Home Office licence.
Other Legal Issues to Consider
Import and Export Rules
Imported products must meet all FSA and Home Office THC thresholds. If a product exceeds the exempt product THC limits, it is classified as a Class B controlled drug, and a Home Office controlled drug import/export licence is required. These licences cost £24 per shipment, with import licences valid for three months. Every shipment must include a Certificate of Analysis and the appropriate customs codes.
Driving After Using CBD
CBD itself is not a controlled substance and is not detected by roadside drug tests. However, the UK has two drug-driving offences: driving whilst impaired (based on visible impairment) and driving over the specified controlled drug blood limit (based on THC concentration in blood). The risk of failing a drug test arises from THC exposure in full-spectrum CBD products or mislabelled items.
A drug-driving conviction carries serious penalties: a minimum one-year driving ban, an unlimited fine, up to six months imprisonment, and a record lasting 11 years. To reduce risk, opt for CBD isolate or broad-spectrum products with a CoA confirming non-detectable or 0% THC, and avoid driving if you feel sedated.
Workplace Drug Tests and CBD
Workplace drug tests in the UK generally screen for THC, not CBD. Employees using full-spectrum CBD products are at higher risk of failing drug tests due to trace THC accumulation. To minimise risks, choose broad-spectrum or CBD isolate products that are confirmed THC-free by third-party lab reports.
Police and CBD Possession
What Counts as Legal Possession?
For a product to be considered legal, it must contain no more than 1mg of THC or other controlled cannabinoids per container. Ingestible products like oils and edibles must also be listed on the FSA Public List in connection with a valid novel food application.
If stopped by police, stay calm and provide the product in its original packaging along with a Certificate of Analysis from an accredited lab confirming THC levels below 1mg. Ensure the product is labelled for wellness purposes rather than making medical claims.
Penalties for Non-Compliant CBD Products
If a product does not meet the Exempt Product Definition, for example, if it exceeds the 1mg THC per container limit or consists of cannabis flowers, penalties under the Misuse of Drugs Act 1971 apply:
-
Possession of a Class B drug: Up to 5 years in prison and an unlimited fine.
-
Supply of a Class B drug: Up to 14 years in prison and an unlimited fine.
-
Police may also issue an on-the-spot fine of £90 for cannabis possession in some circumstances.
These penalties relate specifically to products that are classified as controlled drugs under the MDA (i.e., exceed the 1mg THC limit or are cannabis flowers). Selling a CBD product that lacks full novel food authorisation but meets THC limits is a separate matter governed by food safety law, involving fines and product removal rather than criminal imprisonment.
Understanding UK CBD Laws in 2026: Summary
In 2026, the legal framework for CBD in the UK rests on three core requirements:
-
Products must be listed on the FSA Public List under a valid novel food application.
-
Products must meet the Exempt Product Definition — no more than 1mg of controlled cannabinoids per container.
-
CBD flowers must not be sold or possessed.
The FSA recommends (but does not mandate) that both consumers and businesses adhere to the 10mg/day ADI for CBD. Products suggesting higher daily doses do not align with FSA safety guidance, and businesses are strongly encouraged to reformulate in line with this recommendation.
Local authorities and Trading Standards are actively removing non-compliant products from the market. Both consumers and businesses must stay updated with FSA guidelines to ensure safety and legal compliance.
Frequently Asked Questions
Is CBD legal in the UK in 2026?
Yes, CBD is legal in the UK as of 2026, provided it contains no more than 1mg of controlled cannabinoids (such as THC) per product container and the product is listed under a valid FSA novel food application. CBD flowers and products containing controlled cannabinoids above the 1mg threshold remain illegal under the Misuse of Drugs Act 1971.
How can I check if a CBD product is FSA-compliant?
Check the FSA Public List to confirm the product has a validated novel food application. The product should also come with a Certificate of Analysis from an ISO/IEC 17025 accredited laboratory confirming THC levels are within the legal limit. Be aware that being on the Public List does not mean the product has received full FSA authorisation — it means the application is under review.
Can CBD make me fail a drug test or roadside check?
CBD itself is not detected by roadside drug tests or most workplace drug tests. However, full-spectrum CBD products may contain trace amounts of THC, which could accumulate with regular use and potentially trigger a positive result. To minimise this risk, choose CBD isolate or broad-spectrum products with a CoA confirming non-detectable THC levels. Note that the 0.2% THC limit applies to the cultivation of industrial hemp plants — not to finished consumer products, where the legal limit is 1mg of controlled cannabinoids per container regardless of percentage.
Is the 10mg daily CBD limit legally enforceable?
No. The FSA's 10mg/day acceptable daily intake is advisory guidance only. The FSA has confirmed this limit will not be mandated for products already on the Public List. Businesses are strongly encouraged to reformulate products to meet this guidance, and consumers should be aware of it when choosing products, but exceeding 10mg/day is not a criminal offence.
What are the penalties for selling non-compliant CBD products?
This depends on the nature of the non-compliance. Selling a CBD product that lacks full novel food authorisation but meets THC limits typically results in fines and product removal by Trading Standards under food law. However, if a product exceeds the 1mg THC per container limit, it may be classified as a Class B controlled drug under the Misuse of Drugs Act 1971, in which case supplying it carries a maximum sentence of up to 14 years in prison.
